INFORMED.
LIVE

STRIDES PHARMA SCIENCE LIMITED

BSE: STAR532531ISIN INE939A01011
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹1,220.00+19.95 (+1.66%)
as of 18 Sep 2026
STRIDES PHARMA SCIENCE LIMITED share price, 18 Sep 2025 to 18 Sep 2026: ₹876.15 to ₹1,220.00 (+39.2%). Low ₹796.20, high ₹1,220.00. Volume shown below the price.
52W high
₹1,231.45
52W low
₹769.60
Off 52W high
-0.93%
1M return
+27.48%
3M return
+10.08%
6M return
+34.84%
1Y return
+39.25%
20D avg volume
19,786
50 DMA
₹1,051.38
200 DMA
₹991.85

Key ratios Consolidated

Market cap
₹11,245 Cr
Current price
₹1,220.00
52W high / low
₹1,231.45 / ₹769.60
Face value
₹10.00
P/E
17.72
P/B
EPS (TTM)
₹68.83
Book value / share
ROE
ROCE
21.00%
Operating margin
Net margin
Debt / equity
0.53
Net debt
₹1,480 Cr
Interest cover
4.74
Dividend yield
0.41%
Dividend / share (TTM)
₹5.00
Payout
7.26%
Cash conversion cycle
121.2 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
1,2651,3231,1951,2211,1201,190
4.898.13106.8627.148.5811.98
1,1331,1791,0531,085998.011,072
414.71408.88459.71429.76260.58269.73
166.38127.4571.3841.80120.91231.60
242.99247.11229.54226.78225.52222.86
40.5641.5843.3846.1347.4650.32
56.4053.2550.6249.6448.8948.86
297.46300.40266.22247.22231.86250.69
137.70153.01248.81162.94130.31130.66
63.20-6.41-3.30-8.77-8.37-27.41
200.90146.60245.51154.16121.94103.25
34.1218.7737.3521.5916.4520.76
165.49129.28208.12131.52105.5985.62
17.0213.7721.9313.8410.818.92
Key metrics
297.86241.43339.51249.93218.29202.43
23.50%18.20%28.40%20.50%19.50%17.00%
13.10%9.80%17.40%10.80%9.40%7.20%
4.70%5.50%4.40%
13.00%11.20%
56.70%51.00%
MetricTTMFY26FY25FY24
Income statement
5,0044,8594,565
147.02150.7158.72
4,4494,3144,204
1,7131,5591,476
407.01361.54688.08
946.42928.96862.76
171.65178.54248.85
209.91202.40192.26
1,1111,046919.80
702.46695.06420.42
44.72-26.8464.66
747.17668.22485.08
111.8394.1777.52
634.41574.523,598
66.5660.34390.54
Key metrics
1,1291,049926.19
22.55%21.60%20.30%
12.68%11.80%78.80%
21.00%21.20%
6.40%
-84.00%
279.58441.87
1.220.19
0.530.69
1,4801,683
121.2115.8
Balance sheet
6,9276,049
3,6133,099
188.70112.56
1,2891,203
1,6351,278
227.37
992.43880.69
1,3101,032
2,8952,592
1,6691,796
1,1161,224
552.32571.24
3,1492,586
Cash flow
702.52684.37
-173.04-89.69
-453.41-642.58
422.94242.50
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
582.65605.74553.63522.15498.62555.96
1.483.97103.2414.091.7612.12
575.77583.20522.07510.86483.97539.76
309.11297.46255.50255.66210.98268.29
50.9515.8917.7530.0115.7510.65
102.4095.9495.1496.4994.0491.86
28.5126.6627.2529.4130.4529.36
25.7325.1922.3921.5122.1422.37
114.86121.95104.9581.4295.16113.92
8.3626.51134.8025.3916.4028.32
76.400.000.000.000.000.00
84.7626.51134.8025.3916.4028.32
11.8310.1512.91-6.653.0612.20
72.9316.35121.8932.0413.3516.13
7.911.7713.223.481.451.75
Key metrics
139.0078.36184.4476.3168.9980.05
23.90%12.90%33.30%14.60%13.80%14.40%
12.50%2.70%22.00%6.10%2.70%2.90%
1.50%1.60%1.70%
16.90%9.00%
446.30%1.40%
MetricTTMFY26FY25FY24
Income statement
2,2642,1802,139
122.78123.0646.19
2,1922,1002,108
1,1181,0201,048
114.6079.4062.63
389.97381.60377.59
111.83113.77145.91
94.8291.2484.61
423.18403.47415.86
195.06203.1078.11
76.400.00-0.03
271.46203.1078.08
28.2419.4718.93
243.21183.632,886
26.3819.92313.68
Key metrics
478.11408.11308.60
21.12%18.70%14.40%
10.74%8.40%134.90%
8.90%6.60%
1.90%
-93.60%
109.28255.28
1.510.15
0.350.36
1,1321,150
237.0238.9
Balance sheet
5,3965,031
2,3742,146
16.176.33
1,5211,453
580.27431.71
192.13170.65
634.20606.42
685.59484.85
1,8401,630
1,1481,156
974.891,029
173.25127.37
3,2843,193
Cash flow
277.85421.48
-69.07-137.59
-198.93-370.32
168.57166.20

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
27.92%
HolderTypeHoldingPreviousChange
PRONOMZ VENTURES LLPPromoter19.62%
QUANT MUTUAL FUND - QUANT HEALTHCARE FUNDPublic5.59%
ROUTE ONE OFFSHORE MASTER FUND, L.P.Public5.05%
SBI LIFE INSURANCE CO. LTDPublic4.76%
KARUNA BUSINESS SOLUTIONS LLPPromoter Group3.50%
ROUTE ONE FUND I, L.P.Public2.17%
ARUN KUMAR PILLAIPromoter2.02%
BANDHAN NIFTY TOTAL MARKET INDEX FUNDPublic1.63%
Satpal KhattarPublic1.60%
K R RAVISHANKARPromoter1.36%
ABU DHABI INVESTMENT AUTHORITY - MONSOONPublic1.33%
AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITEDPublic1.28%
MUKUL MAHAVIR AGRAWALPublic1.12%
OMAN INDIA JOINT INVESTMENT FUND IIPublic1.10%
ISHARES CORE MSCI EMERGING MARKETS ETFPublic1.05%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 5.000031 Jul 202631 Jul 2026
Final Dividend - Rs. - 4.000022 Jul 202522 Jul 2025
Spin Off6 Dec 20246 Dec 2024
Final Dividend - Rs. - 2.50009 Sep 20249 Sep 2024

Board meetings

  • Board Meeting - Financial Results